This website is for healthcare professionals and other relevant decision makers only.
Enhancing patient outcomes: the role of clinical utility in guiding healthcare providers in curating radiology AI applications
Digital diagnostics may have an effect on patient satisfaction, outcomes-based agreements, and quality measurements as value-based care continues to shift.
This scientific article provides guidance on the key themes to consider when selecting digital diagnostics based on clinical utility:
-
Unmet clinical burden demands
-
Performance evaluation vs standard of care
-
Influence on patient management
-
Economic implications
![Meet the Digitals Meet the Digitals](https://content.calantic.com/hubfs/Meet%20the%20Digitals.jpg)
"There are so many FDA-cleared or CE-Mark approved AI applications in radiology already, so it is quite difficult to sort out which could be beneficial or not.
With our latest paper we are trying to give guidance on curation of these applications based on clinical utility. This is an attempt to establish a better understanding and a set of tools for healthcare providers who may be considering implementing AI. These AI applications can potentially play a role in impacting quality measures, outcomes-based agreements, and patient satisfaction."
Joana Reis, MD, PhD
Global Medical Affairs Senior Manager for Digital Radiology
-
Complete this form to access the paper
© 2024 Bayer
The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.
BAYER, the Bayer Cross and Calantic are trademarks owned by Bayer and/or registered in the U.S. and/or other countries. Other trademarks and company names mentioned herein are properties of their respective owners.
This is intended to provide information for healthcare professionals and other relevant decision makers in the United States, European Union, United Kingdom and Switzerland. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.
Calantic is ISO 27001 certified. The product Calantic Viewer has CE marking (CE2797). Complies with medical device legislation. Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information. The operating instructions of the product Calantic Viewer can be found on https://www.radiology.bayer.com/manuals
You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect
Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.